Report on mumps outbreak reflects vaccines' limited efficacy

04/9/2008 | WebMD · Reuters

Widespread use of two shots of the mumps vaccine manufactured by Merck & Co. did not prevent a U.S. outbreak of the disease in 2006. Of young adults who became ill, 84% had received the recommended two doses, CDC experts reported Wednesday. The findings suggest a better vaccine or changes in policy "may be needed to avert future outbreaks and achieve the elimination of mumps," the experts said.

View Full Article in:

WebMD · Reuters

Published in Brief:

SmartBrief Job Listings for Health Care